NISA INVESTMENT ADVISORS, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,587
-12.6%
7510.0%0.00%
Q2 2023$21,268
+193245.5%
751
+54.8%
0.00%
Q1 2023$11
-78.0%
485
-72.8%
0.00%
Q4 2022$50
-99.9%
1,7850.0%0.00%
Q3 2022$49,000
+25.6%
1,785
+2.6%
0.00%
Q2 2022$39,000
+200.0%
1,740
+295.5%
0.00%
Q1 2022$13,000
-75.5%
440
-74.3%
0.00%
Q4 2021$53,000
-59.5%
1,710
-39.6%
0.00%
-100.0%
Q3 2021$131,000
-16.0%
2,8300.0%0.00%0.0%
Q2 2021$156,000
+7.6%
2,830
+1.1%
0.00%0.0%
Q1 2021$145,000
+457.7%
2,800
+366.7%
0.00%
Q4 2020$26,000
-69.8%
600
-75.6%
0.00%
-100.0%
Q3 2020$86,000
+168.8%
2,458
+309.7%
0.00%
Q2 2020$32,000
+52.4%
6000.0%0.00%
Q1 2020$21,000
-90.2%
600
-87.1%
0.00%
-100.0%
Q4 2018$214,000
-40.2%
4,6420.0%0.00%
-33.3%
Q3 2018$358,000
+4375.0%
4,642
+2221.0%
0.00%
Q1 2016$8,0002000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders